The mission of the ISCRO is to review research involving human embryonic stem cells, human totipotent or pluripotent cells, human pluripotent stem cell lines, human neural and gonadal progenitor stem cells or other somatic tissues for stem cell research (excluding cells that remain restricted in tissue potential and are not known to possess totipotent or pluripotent potential).
Documentation of the provenance of the material(s) is required.
Overview of the ISCRO Review and Approval Procedure
- The Principal Investigator (PI) is the individual who is primarily responsible for the conduct of the research. Only faculty or staff members may be Principal Investigators. All non-faculty researchers are properly characterized as Co-Investigators.
- The principal investigator must complete the application prescreening form and submit to the committee Chair at email@example.com
- The proposed protocols are reviewed to ensure that the science is appropriate and ethical according to accepted stem cell guidelines (NAS and ISSCR) and that all personnel working with stem cells receive ethical training in their use.
- The approval period is for three years, subject to annual approvals at the end of years one and two.
- All modifications to the approved protocol must be submitted using the Renewal/Update form and re-approved in writing by the ISCRO committee prior to implementation.
Institutional Stem Cell Research Oversight Committee
Deanna Thompson, Ph.D., Chair
Brigitte Arduini, Ph.D., Director, Stem Cell Core
Robert Hull, Ph.D., Institutional Official (IO)